Heybet Tüzün
Heybet Tüzün publishes mostly in Epidemiology, Molecular Biology and Endocrinology, Diabetes and Metabolism, on topics such as Metabolism and Genetic Disorders, Neonatal Health and Biochemistry and Biotin and Related Studies.
- World rank
- #5,801,656 of 7,710,434 ranked researchers
- Rank in Türkiye
- #63,614 of 117,622
- Works
- 21
- Citations
- 250
- Citations per work
- 11.9
What does Heybet Tüzün research?
Heybet Tüzün's work is mostly in Medicine (31%), Biochemistry, Genetics and Molecular Biology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1151.5%
- Health Sciences630.7%
- Medicine630.7%
- Life Sciences417.8%
- 1Epidemiology11% of their works
- 2Molecular Biology11% of their works
- 3Endocrinology, Diabetes and Metabolism8% of their works
- 4Pediatrics, Perinatology and Child Health6% of their works
- 5Clinical Biochemistry6% of their works
- 6Pulmonary and Respiratory Medicine5% of their works
Research topics
- Metabolism and Genetic Disorders
- Neonatal Health and Biochemistry
- Biotin and Related Studies
- Peroxisome Proliferator-Activated Receptors
- Click Chemistry and Applications
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Congenital Heart Disease Studies
Which keywords describe Heybet Tüzün's research?
The keywords of their largest research topics: Newborn Screening, Biochemical Genetics, Glycemic Control, Insulin Therapy, Metabolic Disorders, Glucose-6-Phosphate Dehydrogenase Deficiency, Neonatal Jaundice and Biotin.
- Proximity Labeling
- PPARs
- Critical Care
- Congenital Heart Disease
- Cardiovascular Outcomes
- Biotin
- Glucose-6-Phosphate Dehydrogenase Deficiency
- Insulin Therapy
- Biochemical Genetics
- Newborn Screening
- Glycemic Control
- Metabolic Disorders
- Neonatal Jaundice
- Cardiac Surgery
- Click Chemistry
- Copper-Catalyzed Cycloaddition
- Hyperglycemia
- Peroxisome Proliferator-Activated Receptors
- Type 2 Diabetes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Newborn Screening72 topics
- Biochemical Genetics41 topic
- Glycemic Control42 topics
- Insulin Therapy42 topics
- Metabolic Disorders41 topic
- Glucose-6-Phosphate Dehydrogenase Deficiency31 topic
- Neonatal Jaundice31 topic
- Biotin21 topic
- Cardiac Surgery21 topic
- Cardiovascular Outcomes21 topic
- Click Chemistry21 topic
- Congenital Heart Disease21 topic
- Copper-Catalyzed Cycloaddition21 topic
- Critical Care21 topic
- Hyperglycemia21 topic
- PPARs21 topic
- Peroxisome Proliferator-Activated Receptors21 topic
- Proximity Labeling21 topic
- Type 2 Diabetes21 topic
Where does Heybet Tüzün work?
Heybet Tüzün's main affiliation in the publication record is Diyarbakır Askeri Hastanesi, Türkiye.
How many publications and citations does Heybet Tüzün have?
OpenAlex counts 21 works and 250 citations for Heybet Tüzün, an h-index of 8, ranking #5,801,656 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Heybet Tüzün. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.